Biognosys will be attending Biomarkers UK on May 3-4 in London, UK. You can find us at booth #38. Do not miss the oral presentation on May 3 at 12:30 pm (GMT+1) by our Director of Scientific Alliances, Yuehan Feng.
Oral presentation
An Integrated MS Proteomics Platform from Biomarker Discovery to Customized Assay Panelsheld
State-of-the-art mass spectrometry platform for unbiased biomarker discovery and development of customized assay panels across various biological specimen
Sub-protein resolution allows quantification of proteoforms such as post-translational modifications, isoforms, and mutations
Discovery of biomarker signatures through quantitative profiling of paired CSF-plasma samples from an Alzheimer’s Disease cohort
Yuehan Feng, Ph.D.
Director of Scientific Alliances
(Biognosys)
External oral presentation
Using A Dual Proteomics And Multiplexed IF Approach For The Detection Of Biomarkers Predictive For Response To ICI-Therapy
Identification of over 70 proteins differentially regulated in melanoma patients responding to therapy
Several immune phenotypes, including T cell subsets and M1 TAMs, significantly increased in responders
Anna Juncker-Jensen
Principal Scientist
(NeoGenomics)
